was commenced on paroxetine 30 mg during the sixth month of pregnancy, because of increased depressive symptoms, restlessness and decreased appetite.
M. L. DaM Departmentof MedicalLaboratory

Subjective quality of life in schizophrenia
Sir: Franz et a! (1997) discuss in their paper that atypical neuroleptics may have sub jective quality of life advantages over conventional antipsychotics. Although their assertion may well prove to be true in the future, once we have more robust studies on this subject, I am not sure their conclusions are justified by the results of their study.
They applied the Munich Quality of Life Dimensions List (MLDL-GI) to a group of in-patients on day 10 of admis sion. They compared scores in those receiv ing conventional antipsychotics with those on atypical antipsychotics, and found the latter to have a significantly higher general quality of life. My first point is that they do not seem to have administered a baseline MLDL-GI (i.e. prior to commencing anti psychotics), so we do not know whether the higher scores in the group receiving atypical antipsychotics can be attributed to the medication. It could be possible that this group had higher scores to begin with. Second, the four subscales of the MLDL-GI include physical domain, mental domain, social life and everyday life. Although it may be valid to measure the physical and mental domain of in-patients 10 days after admission, I am not sure about the validity of measuring social life and everyday life in a group of in-patients recently admitted to hospital. Surely, social and everyday life must be measured within the context of the patient's own home and environment. Author's reply: The study to which Dr
Agarwal refers was an open pilot study based on a non-experimental cross sectional design. Assessment of subjective quality of life (SQoL) at baseline would be beyond the scope of such an explorative study. Restrictions to open studies have been discussed in the paper and the findings are, therefore, tested using an experimental double-blind repeated-measures design in a study that has just started. We definitely agree that different patients have different individual levels of satisfaction, which may influence their SQoL ratings.
The quality of life inventory is con structed in such a way that it can be used in whatever circumstances patients live. Hos pital wards sometimes offer more of a â€˜¿ home' to patients than the outside situa tion. Therefore, it is our opinion that validity of the assessment of SQoL in the domains of social life and everyday life does not depend on the place the patient is staying at the time. A patient always has a social and an everyday life. There are fellow patients, the hospital staff or visitors within the hospital, or there are friends and relatives back home. The assessment be comes valid if it really reflects only SQoL and no other dimension within this area of concern. In our study, patients were asked to assess their SQoL in different aspects of their present interpersonal contacts (social life subscale). Whether or not the assess ment in this situation is representative of their predominant way of living is another question. The purpose of the study, how ever, was to investigate the present SQoL of newly admitted in-patients, subsequent to a psychotic exacerbation and taking different kinds of antipsychotic medication, within an exploratory research design.
